106 related articles for article (PubMed ID: 6094685)
1. Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial.
Hokland P; Hokland M; Olesen BK; Ernst P
J Interferon Res; 1984; 4(4):561-9. PubMed ID: 6094685
[TBL] [Abstract][Full Text] [Related]
2. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
Koren HS; Brandt CP; Tso CY; Laszlo J
J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
[TBL] [Abstract][Full Text] [Related]
3. Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.
Saijo N; Shimizu E; Shibuya M; Irimajiri N; Takizawa T; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z; Taniguchi T; Hoshi A
Br J Cancer; 1982 Aug; 46(2):180-9. PubMed ID: 6185128
[TBL] [Abstract][Full Text] [Related]
4. Immunological effects of recombinant interferon-alpha 2 in cancer patients.
Hengst JC; Kempf RA; Kan-Mitchell J; Pham AT; Grunberg SM; Kortes VL; Mitchell MS
J Biol Response Mod; 1983; 2(6):516-27. PubMed ID: 6663321
[TBL] [Abstract][Full Text] [Related]
5. Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.
Saijo N; Shimizu E; Irimajiri N; Ozaki A; Kimura K; Takizawa T; Niitani H
J Cancer Res Clin Oncol; 1982; 102(3):195-214. PubMed ID: 7061569
[TBL] [Abstract][Full Text] [Related]
6. Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.
Merrill JE
J Clin Immunol; 1983 Jan; 3(1):42-50. PubMed ID: 6219125
[TBL] [Abstract][Full Text] [Related]
7. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of cytokines on natural killer and antibody dependent cellular cytotoxicity directed to squamous cell carcinoma targets by lymphocytes from oral cancer patients.
Desai SA; Maniar HS; Rao RS; Fakih AR; Gangal SG
Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):69-73. PubMed ID: 8180580
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
10. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
[TBL] [Abstract][Full Text] [Related]
12. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal administration of human recombinant interferon-alpha in patients with ovarian cancer: effects on lymphocyte phenotype and cytotoxicity.
Lichtenstein A; Spina C; Berek JS; Jung T; Zighelboim J
Cancer Res; 1988 Oct; 48(20):5853-9. PubMed ID: 3167841
[TBL] [Abstract][Full Text] [Related]
14. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
Ernstoff MS; Fusi S; Kirkwood JM
J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.
Poaty-Mavoungou V; Touré FS; Tevi-Benissan C; Mavoungou E
Viral Immunol; 2002; 15(1):197-212. PubMed ID: 11952142
[TBL] [Abstract][Full Text] [Related]
16. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.
Spina CA; Fahey JL; Durkos-Smith D; Dorey F; Sarna G
J Biol Response Mod; 1983; 2(5):458-69. PubMed ID: 6644350
[TBL] [Abstract][Full Text] [Related]
17. Recombinant leukocyte A interferon as single agent therapy or in combination with cimetidine in patients with advanced colo-rectal carcinoma. A phase II investigation.
Flodgren P; Hugander A; Sjögren HO
Acta Radiol Oncol; 1985; 24(1):25-34. PubMed ID: 2984899
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
19. [Effect of chemotherapy on natural killer (NK) activity and antibody-dependent cell-mediated cytotoxicity (ADCC) in carcinoma of the lung and metastatic pulmonary tumor].
Shibuya M
Nihon Ika Daigaku Zasshi; 1987 Feb; 54(1):40-53. PubMed ID: 3558739
[No Abstract] [Full Text] [Related]
20. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
Sung MW; Johnson JT; Van Dongen G; Whiteside TL
Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
